(firstQuint)A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.

.

 The study was conducted in the objective to compare the safety and reactogenecity of BCG Vaccine of Green Signal Bio pharma Private Limited India(Test) with BCG vaccine of Serum Institute of India(Reference) in 120 healthy children.

 The above study was conducted in multi centers(2 centers - Chennai & Bangalore).

 The study was conducted as per the protocol approved by DCGI and Madras ethical Committee.

 A single dose was administedred to all the subjects and it was inferred that all the 120 subjects vaccinated were safe.

 Further, the reactogenecity was confirmed after 90th day by PPD administration to all the subjects.

 Based on the above observations it was well identified that test vaccine can be safely administered to children and it is well tolerated and accepted by the subjects.

 More over statistically it is inferred that there is no significant variation between the test and reference vaccine.

.

 A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.

@highlight

To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited India with BCG vaccine of serum institute of India limited (SIIL), India in 120 healthy children.

